|   
                
               
 
                     
                      |  |   
                      | Complete 
                          your Medical Study in the UK. Medical College of London 
                          is accepting new and transfer students to fill its 
                          September 2002 and later classes. MCL is an affiliate 
                          of the American International School of Medicine (AISM-UK) 
                          and other Academic Institutions in the US and UK, with 
                          innovative curriculum based on UK and USA standards 
                          of medical education. Basic sciences completed at our 
                          Central London Campus, and clinical sciences in the 
                          USA, UK and other International locations. Both 4 and 
                          6 year programs available. Contact Program Coordinator 
                          Dr. Nasiri or Program Director Prof O. Tulp at Tel +44 
                          1223 528 902, FAX +44 1223 529 545, or Email to: LCMTR.edu@ntlworld.com 
                          Send mail inquiries to MCL Admissions, 28A Enniskillen 
                          Road, Cambridge, UK CB4 1SQ. We will review your transcript 
                          of previous medical education without obligation.  |  
  
                   
                  
 U.S. 
                    Corporate Bond Market  Uncertain Times
 By 
                    Scott B. MacDonald  
 We remain constructive about 
                    the rest of the year for the corporate bond market, though 
                    there are many uncertainties - the possibility of another 
                    terrorist attack, the potential for a U.S. war against Iraq, 
                    and a double-dip recession. Another al-Qaeda terrorist attack 
                    on U.S. soil would be a blow to confidence, while it is difficult 
                    to quantify the impact of a U.S. war against Iraq. A double-dip 
                    recession would obviously be a big negative. Although we do 
                    not rule out a double dip recession, we expect the U.S. economy 
                    to muddle through. The combination of auto sales, mortgage 
                    refinancing, and housing, plus one more Fed interest rate 
                    cut, will allow the economy to slide by at around 2.5% for 
                    2002. That stated, we still expect investors to remain very 
                    sensitive to any negative news on the economy and to remain 
                    focused on corporate earnings (in late September and October 
                    for Q3). The equity market will continue to be exceedingly 
                    volatile, with seismic-like daily shifts.
 Much depends on restoring investor confidence. In August, 
                    when we enjoyed a short-lived equity market rally, the corporate 
                    bond market saw spread tightening and new issuance. During 
                    the third week of August, 28 issuers came forward and brought 
                    $16.36 billion in bonds to market, the largest weekly number 
                    since March 2002s $26.9 billion. While some economic 
                    numbers helped nudge the rally, there was also a sense of 
                    relief that most major companies made it through the August 
                    14th CEO and CFO earnings accountability signings without 
                    major problems. Indeed, the corporate governance issue, barring 
                    any new scandals, is likely to fade as a concern.
 
 It is estimated that potential new investment grade corporate 
                    bond issuance for the remaining months of 2002 could be between 
                    $90-$100 billion, at least part of which comes from the need 
                    to refinance as debt comes due. The next major trigger for 
                    the corporate bond market is likely to be Q3 corporate earnings, 
                    which start in late September. As corporate governance issues 
                    fade, attention will return to more fundamental credit concerns 
                    about profitability, debt management, and liquidity. Related 
                    to this is the pace of the economy. Most economists are looking 
                    for real GDP growth in Q3 in excess of 3%, followed a slower 
                    pace in Q4. That could help provide some traction for better 
                    corporate earnings through the end of the year. However, there 
                    remains considerable nervousness in corporate America and 
                    most managers are still looking to trim capital spending -- 
                    not increase it. The earnings announcements of the large brokerages, 
                    such as Morgan Stanley, thus far have not set a positive tone. 
                    JPMorgan Chases problems, including ratings downgrades, 
                    have not helped.
 
 It should also be understood that the drop in U.S. unemployment 
                    from 5.9% to 5.7% was largely due to job creation in government, 
                    while manufacturing actual had a drop in employment. As we 
                    see consumer demand remaining in positive territory, the most 
                    likely outcome is that the economy on a whole will not get 
                    much worse, but it will not get much better. The same can 
                    be said for the corporate bond market.
   
 (click 
              here to return to the table of contents) 
								 
 Editor: Dr. Scott B. MacDonald, Sr. Consultant Deputy Editor: Dr. Jonathan Lemco, Director and Sr. Consultant  Associate Editors: Robert Windorf, Darin Feldman  Publisher: Keith W. Rabin, President  Web Design: Michael Feldman, Sr. Consultant Contributing Writers to this Edition: Scott B. MacDonald, Keith W. Rabin, Uwe Bott, Jonathan Lemco, Jim Johnson, Andrew Novo, Joe Moroney, Russell Smith, and Jon Hartzell 
								 
 
 
 
       |